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Targeting the cancer cell cycle by cold
atmospheric plasma
O. Volotskova1, T. S. Hawley2, M. A. Stepp3 & M. Keidar1
1Dept. Of Mechanical and Aerospace Engineering, The George Washington University, SEAS, 801 22nd St. NW, Phillips Hall 735
Washington, DC 20052, 2Flow Cytometry Core Facility, The George Washington University 2300 I St. NW, Ross Hall 118
Washington, DC 20037, 3Dept. Of Anatomy and Regenerative Biology, The George Washington University, SMHS, 2300 I St.
NW, Ross Hall 226C Washington, DC 20037.
Cold atmospheric plasma (CAP), a technology based on quasi-neutral ionized gas at low temperatures, is
currently being evaluated as a new highly selective alternative addition to existing cancer therapies. Here, we
present a first attempt to identify the mechanism of CAP action. CAP induced a robust ,2-fold G2/M
increase in two different types of cancer cells with different degrees of tumorigenicity. We hypothesize that
the increased sensitivity of cancer cells to CAP treatment is caused by differences in the distribution of
cancer cells and normal cells within the cell cycle. The expression of cH2A.X (pSer139), an oxidative stress
reporter indicating S-phase damage, is enhanced specifically within CAP treated cells in the S phase of the
cell cycle. Together with a significant decrease in EdU-incorporation after CAP, these data suggest that
tumorigenic cancer cells are more susceptible to CAP treatment.
T
he complex nature of cancer makes it difficult to develop effective treatments. Targeted cancer therapies are
defined as substances or methods that block tumor growth by interacting with specific molecules or that focus
on treatments to cancer specific molecular and cellular changes. Several targeted cancer therapies exist today.
Examples include chemotherapy, radiotherapy and molecularly targeted drugs1–3. One way to target cancer cells is
to interfere with the cell cycle. Cancer cells proliferate at a faster rate than normal cells4. Combination therapies are
proved to be most effective; they impact cancer cell biology at multiple signal transduction pathways resulting in a
synergetic effect. The goal is to trigger cells to execute what has been referred to as ‘‘the cell death pathway’’ or
apoptosis. A major hurdle in treating cancers is preserving surrounding normal tissue while inducing cell death
within cancer cells within a tumor. While progress is being made at developing treatments that are selective for
cancer cells, cancer treatment induced damage to normal cells within tissues remains a major problem in oncology.
Recently, it was reported that newly developed cold atmospheric or non-thermal plasmas (CAPs) could be used
as an alternative therapies for cancer5,6. It was shown in vivo that tumor size can be decreased when CAP
treatment was applied locally. Analysis of the CAP effect in vitro revealed that cancer cells die due to apoptosis.
It was reported early that the reactive oxygen species (ROS) are the major players in the cell response to CAP
treatment in vitro and in vivo. Additional effects of cold atmospheric plasmas on the living tissue at various levels
were shown: plasma sterilization, improvement in wound healing, cell migration changes, changes in the protein
expression7–12. The variety of different effects of plasma can be explained by the complex chemical composition of
CAP and variations in the way that CAP is generated. In fact, CAP is a cocktail containing variety of ROS, reactive
nitrogen species, charge particles, UV etc. This variety leads to themyriad of effectsmentioned above.Whilemost
studies tackle individual effects related to particular application of interest, there are few studies that correlate cell
responses and intracellular dynamics. While we have looked at CAP effects on integrin mediated cell adhesion
and signaling in normal and skin cancer cells, our studies only begin to address the mechanism of plasma action
on cancer cells remains elusive.
In this study, we set out to correlate the changes seen in cell motility observed previously13 in normal primary
skin cells with viability and cell cycle progression under CAP treatment. We hypothesize that cancer cells are
more susceptible to the effects of CAP because a greater percentage of cells are in the S phase. To test our
hypothesis, we used normal cells derived from mouse skin as well as two mouse skin cancer cell lines. The skin
is the largest human organ and includes 15–20% of total body mass. The outer layer of the skin, the epidermis, is
composed primarily of keratinizing stratified squamous epithelial cells. Two competing processes sustain the
thickness of the epidermis: proliferation and terminal differentiation of keratinocytes; both processes are driven
by specific signaling pathways. Disturbances of cell-matrix, cell-cell adhesion, or terminal differentiation can lead
to homeostatic imbalance in various diseases including skin cancers. Reduced terminal differentiation of skin cells
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allows the cells to continue proliferating and is a common feature of
skin cancers14,15. Here we compare CAP responses of normal primary
mouse keratinocytes with those of two well studied mouse skin can-
cer cell lines that were derived from normal mouse keratinocytes.
While the two cell lines consist of transformed keratinocytes, they
vary in their ability to induce tumors when injected into mice, a
property referred to as tumorigenicity. One line (308) generates
benign tumors called papillomas whereas the other (PAM212) gen-
erates carcinomas16–18.
We report that CAP treatment induces a delay in progression of
skin cancer cells through the cell cycle by increasing the numbers of
cells at the G2/M checkpoint,24 hours after treatment and that this
delay correlates with increased expression of cH2A.X (pSer139) and
DNA replication decrease in the S phase of the cell cycle. cH2A.X
(pSer139) is an oxidative stress reporter indicating S-phase damage.
These data can be exploited to ensure that therapies developed using
CAP in combination with other therapies induce optimal results and
minimize damage to healthy tissues.
Results
CAP effect on the cell migration and velocity distribution among
the chosen cell population. First we identified how CAP affects
migration of normal and transformed epithelial cells. The right
panel of the Figure 1A – C shows the dependence of cell migration
rates on the length of the CAP treatment from 0 to 180 seconds.
For each time point ,50–60 cells were analyzed. The cell velo-
cities/migration rates and cell numbers were normalized. Statistical
analysis of the data showed that wild type keratinocytes (Figure 1A)
and PAM 212 cells (Figure 1C) have a statistically significant change
in the migration rates beginning 40 seconds of CAP treatment. The
migration rates for WTK and PAM212 cells after 60 seconds of CAP
is,30% and,20% less than untreated cells; these changes are well
identified by velocity distribution function of the cells and become
even more statistically significant. The left panel of the Figure 1A–C
shows the probability distribution functions (PDF) of the cell
migration rates (distribution of cell velocities) for untreated cells
(control, blue) and cells treated with cold atmospheric plasma for
Figure 1 | CAP effect on the cell migration and velocity distribution among the chosen cell population. The dependence of the cells migration rates on
the length of the CAP treatment from 0 to 180 seconds are shown for WTK, 308 and PAM 212 cells (Figure 1A–1C, left panel). SEM (standard error of
mean) is shown with an error bars. For each time point ,50–60 cells were analyzed. The difference between groups were considered statistically not
significant for p-value. 0.05 (nomark) and for p-value, 0.05 (single star), p-value, 0.01 (double star) and p-value, 0.001 (triple star) are considered
significant. The probability distribution functions (PDF) of the cell migration rates (distribution of the cell velocities) for untreated cells (control, blue)
and cells treated with cold atmospheric plasma for 60 seconds (plasma treated, red) are shown for WTK, 308 and PAM 212 cells (Figure 1A–1C, right
panel). The experimental data (,250 cells of each cell type were analyzed for each condition) is fitted with inverse Gaussian distributions.
www.nature.com/scientificreports
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60 seconds (plasma treated, red). The experimental data (,250 cells
of each cell type were analyzed for each condition) are fitted with
inverse Gaussian distribution, which describes the first passage in
Brownian motion with positive drift19. For normal and transformed
(PAM 212) cells, longer CAP treatments increased the reduction of
cell migration. CAP treatment for ,120 seconds gave the upper
threshold in the cell migration reduction for the chosen time
treatment range (see inserts in Figure 1A and 1C). Unlike normal
and PAM212 cells, 308 cells did not show any significant change in
their migration rate after plasma treatment. It is important to note
that 308 cells have very slow motility; their average velocity is
approximately 10 fold less than WTK and PAM212 cells. The cell
velocity distribution of WTK cells showed the most apparent
negative shift from control under the mild CAP treatment, unlike
PAM212 cells. The cells were also treated with helium only for 60
seconds, no significant differences in migration rates were found
(p-value . 0.05, data not shown).
Cell viability studies in two threshold regimes. The experiments
presented in Figure 1 indicate that cell migration rates of normal and
PAM212 cells are sensitive to CAP. By plotting the data using PDF,
data show that after CAP, migration rates of normal and PAM212
cells cluster more tightly indicating reduced variability among cells
within the population. To determine whether there were differences
in cell viability among adhered normal WTK, 308, and PAM212
cells, an MTT assay was performed.
The MTT assay results are shown in Figure 2A – C for WTK, 308
and PAM212 cells respectively. The assay was performed 4, 24 and
48 hours after two threshold regimes of CAP treatment: 60 seconds
(low threshold) and 120 seconds (upper threshold) were used to
identify changes in cell viability. WTK cells viability decreased by
30% and 50% after 60 and 120 seconds of CAP treatment in
,4 hours after treatment. By 24 hours, cell viability after CAP
recovers after both treatment lengths (Figure 1A). The viability of
308 cells was not changed 60 seconds of CAP treatment, but was
significantly reduced after 120 seconds of CAP treatment in,4 and
48 hours (see Figure 2B). PAM212 cells responded to CAP treatment
with a 30% and 40% decrease in viability after 60 and 120 seconds
respectively 4 hours after treatment. While 308 cell viability recov-
ered 24 hours after treatment, similar to 308 cells, PAM212 cells
showed reduced viability 48 hours after 120 seconds of treatment
(Figure 2B, C). No viability differences were observed after 60 sec-
onds of CAP treatment at ,24 and 48 hours for all types of cells.
Based on these data, CAP treatment for 60 seconds was chosen. This
treatment regime induces a change in cell migration in normal and
PAM212 cells and causes no significant effect on cell viability 24 and
48 hours after treatment, thus allowing determination of the ini-
tiation of the CAP effect on the cells. So the following studies were
made for 60 seconds of CAP treatment.
We also used flow cytometry to estimate the number of control
(untreated) adhered cells per well for chosen time points (data not
shown): 308 and PAM 212 cells expand fast: having a double-triple
fold increase at each chosen time point. The numbers of normal
keratinocytes adherent on tissue culture dishes do not change over
time in vitro significantly. In fact, the number of normal keratino-
cytes decreases on the 3d day due to the onset of terminal differenti-
ation and this fact is reflected by MTT data.
Identification of the cell cycle changes in G2/M-phase. Next we
identified the CAP effects on the cell cycle of normal, 308 and
PAM212 cells. Figure 3A–3C are bright-field images with 10X
magnification of wild type keratinocytes, 308 and PAM212 cells
morphology, respectively. Figures 3D–L are DNA content mea-
surement of control (untreated) cells in blue, and cells treated with
CAP for 60 seconds in red. The cells were analyzed in ,4 hours
(Figure 3 D, E, F), ,24 hours (Figure 3 G, H, I) and ,48 hours
(Figure 3 J, K, L) after 60 seconds of CAP treatment. No significant
shifts in the G1 – G2 peaks positions were observed for all of the cell
types. The results were analyzed with Watson (pragmatic) cell cycle
model (FlowJo 7.6.5 software), which does not make any assumption
about the S-phase distribution. The data were characterized by
the fraction of the cells in the G2/M–phase as well as the coefficient
of variation (CV) for control (untreated) and CAP treated cells. CAP
induced robust G2/M–cell cycle increases in both carcinoma (Figure 3I)
and papilloma (Figure 3H) cells (2-3-fold increase in ,24 hours after
CAP treatment), whereas normal keratinocytes (Figure 3G) showed
a more modest cell cycle increase. This change diminished in
,48 hours. The coefficient of variation (CV, a normalized measure
of dispersion of a probability distribution) was used to characterize
the data. For all 3 time points, wild type cells showed ,15–20% CV
Figure 2 | Cell viability studies in two threshold regimes. MTT assay was
performed on: (A) wild type keratinocytes (WTK), (B) 308 cells
(papilloma) and (C) PAM212 cells (carcinoma). Control (not treated) is
shown in blue, CAP treated for 60 seconds – in red and CAP treated for 120
seconds – in grey cells at 0, 4 and 24 hour time points. SEM is shown with
an error bar. The experiment was repeated 3 times for each cell type and
condition. Three stars denote extremely significant statistical difference
(p-value, 0.001), one star – statistically significant difference (p-value,
0.05), data was considered statistically not different for p-value . 0.05.
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 2 : 636 | DOI: 10.1038/srep00636 3
values for the cells in G2/M-phase, while transformed cells had CV
value of ,6–10%.
Studies of the cell population’s distribution during the cell cycle
under CAP treatment. In order to determine if increased prolife-
ration of the cells might result in the above observed G2/M increase
24 hours after CAP treatment, we carried out a more detailed anal-
ysis of the cell cycle. Cells were treated with the nucleotide analog
EdU which is incorporated into DNA as it is being replicated. After
staining EdU treated cells with a dye that binds to DNA (Propidium
Iodide or PI), flow cytometry was used to assess the numbers of cells
in the three distinct phases of the cell cycle (G0/G1, S, and G2/M)
simultaneously for all three cell types; data are shown in Figure 4A–F.
Results are presented for the time point 24 hours for the control (un-
treated) cells and CAP treated cells for 60 seconds. As expected, fewer
normal cells were in S phase (,10%) compared to the two cancer cell
lines (transformed cells are highly proliferative):,50% for 308 cells
and ,45% for PAM212 cells. No increase in the fraction of cells in
the S-phase after CAP treatment was observed for the three cell types:
their number either remained the same or decreased. However, we
did observe an increase in the ranging of standard deviation value of
CAP treated cells in S-phase of around,20% for all three cell types
suggesting that not all cells within the population of cells responded
the same to CAP treatment. While we did not see a significant
difference in the numbers of cells in the S phase of the cell cycle,
we did see that the number of cells in the G2/M fraction increased by
,25% for normal cells and 2- to 3-fold for transformed cells. The
increase in the fraction of cells at the G2/M phase of the cell cycle is
accompanied by a decrease in the number of cells in the G0/G1 fraction.
This study also shows the general trend in the distribution of cells
Figure 3 | Identification of the cell cycle change in G2/M-phase. Figure 3A–3C Bright-field images of wild type keratinocytes (WTK), epidermal
papilloma (308 cells) and epidermal carcinoma (PAM212 cells) cells are shownwith amagnification 10x. Figure 3D–3L show cell cycle studies: Propidium
Iodide content (horizontal axis) and normalized number of cells (vertical axis) are shown. The controls are shown in blue and cells CAP treated for 60
seconds are in red. The ratio of the number of cells (treated to untreated) in G2/M-phase with coefficients of variation (CV, in percents) is shown in the
right top corner of each figure. Figure 3D – 3F shows cell cycle measurements in,4 hours; Figure 3G–3I in,24 hours; and Figure 3J–3L in,48 hours
after the CAP treatment for WTK, 308 and PAM 212 cells respectively. The data is shown for,25000–50000 cells for each experimental condition. The
measurements were repeated 2–3 times.
www.nature.com/scientificreports
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within the cell cycle and indicates that timing of the cell cycle is
different for chosen cells.
Cell synchronization for G2/M peak increase studies. We next
designed an experiment to determine whether cells synchronized
at the G2/M phase of the cell cycle and released would also show
an increase in accumulation at the G2/M checkpoint. 308 cells were
chosen for these studies because they showed a robust G2/M-peak
increase after CAP treatment. On the other hand 308 cells did not
express any significant changes in the migration after CAP was
applied. This makes 308 cells most appropriate example to distin-
guish between the cell migration and the cell cycle effects of CAP.
Cells were synchronized with nocodazole, a drug that interferes
with microtubule polymerization and causes mitotic spindle arrest,
thereby preventing cells from entering mitosis; the effect is reversed
upon its removal. The drug was removed and cells were treated by
CAP in,2 hours after removal of nocodazole. Figure 5A shows the
time dynamics of the cell cycle immediately after nocodazole
removal (0 hours point), at the ,4 hour time point (it is around
the time of CAP treatment) and in ,24 hours after CAP
treatment when G2/M-increase was observed. Figure 5B shows the
detailed distribution of cells among phases of the cell cycle 24-hour
time point of the cells pre-treated with nocodazole including CAP
treatment. Cell synchronization did not impact the G2/M pause
induced by CAP. The coefficient of variation holds , around 5–
7%, while the fraction of the cells in G2/M-phase doubled in
,24 hours after CAP treatment of nocodazole pre-treated cells.
The cell cycle of cells pre-treated with nocodazole only restored to
Figure 4 | Studies of the cell population’s distribution during the cell cycle after CAP treatment. The detailed studies of the cell cycles for control and
CAP treated for 60 seconds cells are shown. The correlation between DNA content (Propidium Iodide) and DNA-replicating cells (EdU-component) is
shown for: Figure 4A, 4B – normal cells (wtk); Figure 4C, 4D–papilloma cells (308 cells); and Figure 4E, 4F–carcinoma cells (PAM212 cells) in,24 hours
after CAP treatment. Coefficient of variation (CV) was used to characterize the Propidium Iodide data (linear scale) and standard deviation (StDev) was
used for EdU-data (log scale) in each phase. Fractions of the number of cells in each cell cycle phase are shown in percents. The data is shown for,25000
cells for each experimental condition. The experiments were repeated 2–3 times.
www.nature.com/scientificreports
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control (not treated) cells profile in,24 hours. The variation of the
data spread for cells in S-phase for CAP treated cells was again,20%
more than cells pre-treated with nocodazole only. This data also
suggested that dynamics of the cell cycle in 308 cells is rapid.
Nocodazole caused ,4-fold increase in the number of cells in the
G2/M phase of the cell cycle. When nocodazole is removed, by
,4 hours cells begin progressing in synchrony from G2/M to G0/
G1 and the ratio of the cells in G2/M-phase falls to,2-fold increase
with the accumulated DNA-replicating cells in S-phase. Thus, we
cannot conclude from this study whether or not CAP impacts cells
within S phase or G2/M-phase. However, we can state that G2/M-
pause after CAP occurs whether or not cells have been synchronized.
CAP targets the cell cycle. To directly test whether CAP impacts
some cell-cycle phase specifically, experiments were designed to
assess the expression of cH2A.X (pSer139) at different phases of
the cell cycle. Based on the earlier experimental results shown, we
surmised that the G2/M-peak increase could be due to effects exerted
on cells in the S and/or G2/M phases. It was previously reported
by Keidar et al. (2011) that CAP based on helium flow may induce
ROS response in the cells5. Thus, we choose cH2A.X (pSer139) as an
oxidative stress reporter of S-phase damage. This histone comprises
around ,2–25% of the evolutionarily conserved variant of histone
H2A, it goes through a post-translational modifications in response
to ionizing radiation, UV-light or ROS20,21. It can be used in com-
bination with EdU-labeling to determine if the oxidative stress is
induced in S-phase22. Figure 6 shows the results of time sensitive
308 cell response studies to CAP treatment of 60 seconds: DNA
content in cells, DNA replicating cells and cH2A.X expression
were measured simultaneously. Figure 6A shows the cell cycle
dynamics (EdU/DNA content) of 308 cells immediately following
and at 4 and 24 hours after CAP treatment. Note the very significant
change in the S-phase signal (EdU) at ,0 and ,4 hours: almost 2-
fold decrease in the median value with decrease of variation range
value (see Figure 6 for detailed analysis), while still no significant
changes were observed in G0/G1 and G2/M; at the,24 hours time
Figure 5 | Cell synchronization for G2/M increase studies. 308 cells were synchronized with nocodazole and analysis of the cell cycle was carried out for
various time points. Figure 5A shows the time evolution of the 308 cells: the control cells (not treated cells) is shown in blue, the cells pre-treated with
nocodazole is in orange and nocodazole pre-treated cells whichwere CAP treated for 60 seconds – in red. The cell cycle evolution after nocodazole removal
is shown at,0, 4 and 24 hour points. The cells were treated with CAP at time point,2 hours after nocodazole removal (the state of the cell cycle for this
time point is not shown). The final state of the systems control (not-treated cells), cells pre-treated with nocodazole only and cells pre-treated with
nocodazole and treated with CAP is shown for time point ,24 hours. The change in ratio between G2/M fractions of the cells at each experimental
condition is marked with a red square. Figure 5B shows detailed cell cycle studies of 308 cells for chosen time point ,24 hours .The DNA content
(Propidium Iodide, linear scale) and DNA-replicating cells (EdU-component, log scale) characterized by CV (in percents) and StDev (arb. units) values,
respectively. The data is shown for ,25000 cells. The measurements were repeated 2–3 times.
www.nature.com/scientificreports
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Figure 6 | CAP targets the cell cycle phase. The time sensitive studies of the 308 cells cell cycles are shown for the time points ,0 hour,,4 hour and
,24 hours points after 60 seconds of CAP treatment. The control (not treated cells) is shown in blue, CAP treated cells is in red. Figure 6A shows the time
evolution of the cell cycles (DNA content – vs. – DNA replicating cells) of control and CAP treated cell. The changes in EdU and cH2A.X signals are
characterized by K-S maximum difference Dmax and Dcr values at the selected time point. Figure 6B shows the correlation between DNA content and
cH2A.X reporter for G0/G1 cell phase; Figure 6C shows correlation between DNA replicating cells (EdU) and cH2A.X for 308 cells in S-phase; and
Figure 6D shows correlation between DNA content and cH2A.X for the 308 for G2/M-phase for,0,,4 and,24 hours time points.,25000 cells are
shown for each experimental condition. Changes in the fraction of cells between the control (not treated) and CAP treated cells are shown for each cell
phase: cell number decreases if the ratio is less than 1. The statistical description of the signals shown in the Figure 6A is a maximum differences between
two distributions in the S-phase with confidence interval 99.9%; in the Figures 6B–6D Dcr – value is shown: Dcr , 1.3581 (p . 0.05) is considered not
statistically significant and Dcr . 1.9526 (p , 0.001) is extremely statistically different
29.
www.nature.com/scientificreports
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point the S-phase recovered and the number of cells in G2/M 24 hours
after CAP treatment was increased. Figures 6B–6D represents the
correlation between cH2A.X signal and DNA content in G0/G1-
phase (B); with EdU incorporation to highlight S-phase cells (C),
and with DNA content to highlight cells in G2/M-phase (D). There
were no significant differences in cH2A.X (pSer139) expression in cells
at G0/G1 at any time point (Figure 6B). There was an increase in
cH2A.X (pSer139) expression (maximum difference Dmax ,30% at
time point 4 hours) correlated with ,2-fold decrease in the EdU-
signal in cells mostly in the S phase immediately (0 hours) and
4 hours after CAP treatment (Figure 6C). Differences in cH2A.X
(pSer139) expression were less apparent 24 hours after CAP treat-
ment: G2/M phase showed some increased variation of cH2A.X
(increased ranging value of standard deviation with some increase in
the median value) at the time point,24 hours, which correlated with
the increase of the number of cells (G2/M increase, corroborating
earlier observations, Figure 6D).
Discussion
It has been shown at the cellular level that cold atmospheric plasma
(CAP) could be used as alternative tool for cancer therapy. The effect
of CAP on cells depends on the length of the time cells are treated
with a specific power, the chemical composition (helium flow based
jet),and the number of cells within the population treated that are in
the S-phase. Normal skin cells are less likely to be in S-phase of the
cell cycle compared to cancer cells. Regardless, their migration rate
and viability are transiently reduced bymild CAP treatment. Normal
skin cells do not induce tumors when injected into mice; two differ-
ent cancer-causing cell lines do cause tumors18. More tumorigenic
cell line (PAM212), like normal cells, also shows reduced migration
rates and viability after mild CAP treatment but the other cell line
(less tumorigenic papilloma cells) shows neither reduced migration
rates nor reduced cell viability. To determine the underlying causes of
these differences, detailed cell cycle assessments were conducted on
the CAP treated cells. These data show that CAP affects all stages of
the cell cycle, however depending on the phase of the cell cycle in
which a cell exists the outcome of the CAP treatment or the cell
response is different. We track only those cells that do not undergo
mitosis over the 16 hr and 40 min time period; the cells are subjected
to time lapse were most likely in G0/G1 or S-phase. Experiments
using dermal fibroblasts and epithelial cells suggest that differences
in integrin expression and/or activation (conformational changes on
the cell surface) cause the cell migration effects induced by CAP23,24.
Themigration rate of 308 cells is very slow (,10-fold less) compared
to normal keratinocytes and PAM212 cells. Despite the fact that CAP
had no effect on cell migration in 308 cells, our detailed analyses of
the cell cycle and expression of cH2A.X (pSer139) in these cells
shows that they do respond to CAP treatment. Like normal cells
and PAM212 cells, 308 cells undergo transient G2/M pause after
CAP.
The experiments presented show that the phosphorylation of his-
tone cH2A.X was most evident in cells in S-phase (median rise up to
,35%); however, a not-quite mathematically significant increase
was also observed in G2/M. The increase of cH2A.X expression
correlated with an abrupt decrease in the median value of EdU signal
that started immediately after CAP treatment and continuing at the
4-hour time point. Thus, CAP causes reduction in progression of
cells through S phase (DNA-replication slows down), induces oxid-
ative damage to DNA, indicated by phosphorylation of histone
cH2A.X on serine residue 139, leading to the accumulation of cells
at the G2/M checkpoint caused by the DNA damage.
The kinetics of cH2A.X phosphorylation suggests that CAP treat-
mentmost likely is not related to Double-Strand Breaks25 confirming
earlier experimental findings6. It has also been shown that phos-
phorylatedH2A.X forms nuclear foci at the sites of stalled replication
forks in response to exposure of S-phase cells to UV radiation and
chromatin changes or modifications play a role in the replication
block pathway26. The spectral analysis of CAP jet showed that most
of species were excited at the UV range (280–450 nm), providing a
possible explanation for induction of S-phase damage, however ROS
stresses has to be taken into account as well13. With the mild CAP
treatment, only a,10% decrease in the number of S-phase cells was
detected, so this treatment (as MTT also showed) does not kill skin
cells effectively. But as shown on the Figure 2, increasing the treat-
ment length to 120 seconds decreases the viability of the cells. The
fact that most of the reduction appeared in ,48 hours could be
explained by the initiation of apoptotic pathway in those cells in S-
phase which subsequently did not recover. This is in the agreement
with results previously shown by Yan et al7. In ,24 hours, restora-
tion of the S-phase of the cell cycle was accompanied by an increase in
Figure 7 | The schematic model of the CAP impact on the cell cycle. Figure 7A is the schematic representation of the cells distribution during the cell
cycle phase for analyzed types of cells: WTK, 308 and PAM212. Figure 7B is schematic of the CAP affect on the cell cycle with consequent cell response.
www.nature.com/scientificreports
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G2/M peak, indicating that the CAP treated cells progressed into the
G2/M phase. We did not observe significant differences in G2/M in
normal keratinocytes where,10–15% of cells within the population
are in the S-phase; ,40-50% of cancer cells are in the S-phase.
Figure 7 shows the correlation of the CAP-induced effects with
various types of cells. The 308 cells are different in many ways from
the PAM212 cells despite that fact that both cells lines arose from
mouse keratinocytes in the same laboratory at the NCI at the NIH. It
would be necessary to study in detail several additional sets of normal
and transformed cells before we could definitively conclude that
increased susceptibility to CAP correlates with tumorigenicity of
the cells. The progression of these two cell types through the cell
cycle is different and one should take into account that the strength
of the treatment effect correlates with the time point chosen for
analysis. However, the data we produce here goes a long way towards
proving that mild CAP impacts DNA synthesis and causes a tran-
sient cell cycle pause at the G2/M phase of the cell cycle; and that
overall CAP impact on the migration rates, viability and cell cycle
increases on the cancer cells as they are more tumorigenic (see
Figure 1,2,3). It’s important to note here that other cancer cell lines
and in vivo models tested with the similar CAP treatment conditions
showed some variation in resistance and timing for the cell cycle
effects, which is determined by their differences5,6.
The overall effect of CAP on the cells will be a combination of
various physical phenomena including the interaction of electromag-
netic radiation (UV/VUV, visible light, IR, high-frequency electro-
magnetic fields, etc.) with ions, electrons, and reactive chemical
species (ROS or RNS). It is not clear yet what particular component
induces oxidative stresses in cells. CAP could directly and/or indir-
ectly cause formation of intracellular ROS. From our data and others,
it appears that in vivo, we will face a cumulative or synergetic effect of
CAP as discussed by Vandamme et al6. Our data show that depend-
ing on the phase a cell is within the cell cycle and the adhesion of that
cell to the substrate, CAP effect varies. In more advanced biological
systems (tissues and organs) which consist of networks of commun-
icating and interacting cell types, the effect of CAP will undoubtedly
be more complicated.
Methods
One should note that only attached cells were analyzed, since it is known that kera-
tinocytes in vitro tend to have floaters and it is impossible to include them in cell
motility analysis. The migration rates in the presented data are the results of indi-
vidual cell tracking (not a sheath) and flow cytometric cell analysis techniques enable
characterization of large numbers of individual cells.
Cell culture.Wild Type Keratinocytes cells (WTK, the procedures used to isolate and
cultivate cells frommice were authorized and approved by the GWUMC Institutional
Animal Care and Use Committee; wt mice (BALB/c) were obtained from NCI-
Frederick)16, 30817 and PAM 21218 cell lines were obtained from NIH NCI Dr. S.H.
Yuspa Group.
Cell culture dishes were pre-coatedwith Fibronectin/Collagen I solution (FN/CN I,
10 mg/ml fibronectin from BD Bioscience, Pasadena, CA, cat# 354008/1% collagen
type I from Advanced BioMatrix, San Diego, CA, Part# 5005) for 20 min and incu-
bated at 37uC. Firstly cells were plated in special plating medium and incubated at
37uC for 28–20 hours, then washed twice with PBS (Dulbecco’s Phosphate Buffered
Saline without Calcium or Magnesium, Lonza cat# 17-512F) and incubated in Low-
Calcium Medium for ,24 hours at 37uC. Low-Calcium Medium with calcium
concentration ,0.05 mM was prepared from 500 ml Minimum Essential Medium
(S-MEM, Invitrogen Lot# 652978, Formula# 98-0216OJ) with 1.1 ml Pen-Strep
Solution (Invitrogen, Gibco, cat# 15140) and 36 ml of Chelexed Fitum Bovine Serum.
High-Calcium Medium with calcium concentration,1.4 mM was made from Low-
Calcium Medium with addition of 2.2 ml of Calcium Chloride 0.296 M. The plating
mediumwas prepared bymixingHigh-Calciumwith Low-CalciumMedia in the ratio
1:6. Cell confluence ,50–60% was used for cell tracking studies, for other experi-
ments the confluence was ,70%.
CAP (cold atmospheric plasma) jet.The cold atmospheric plasma jet is the dielectric
barrier discharge in helium that is described elsewhere27. The working parameters
were: the output voltage was about 4.5–5 kV, the frequency ,13 kHz, the helium
flow rate,10 L/min. The distance between the jet outlet and culture plate was kept
about 20 mm. The average jet dose at the distance 20 mm from jet outlet,0.8 J/sec
cm2 was determined from (Shashurin APL 2009, 28). The CAP jet represents itself the
streamer ‘‘plasma bullet’’ propagating along with gas flow with the velocity is about
23106 cm/sec27. Plasma density in the streamer head was about 5–1031013 cm23 28.
The ionized nitrogen species and highly reactive oxygen radicals are presented in the
CAP spectrum13. We used helium as a control to establish the experimental
conditions: the initial depth of the media,2 mm would not allow desiccation of the
cells during the chosen CAP treatment times. All experiments with cold plasma were
conducted on the 3rd day after cell plating. Epithelial cells were prepared and
equivalent numbers plated onto culture plastic dishes and maintained in Low-
Calcium medium at 37uC during the plasma treatments. No temperature increase of
the media was observed after CAP treatment. Fresh medium was added to the cells
following plasma treatment. All experiments were duplicated and repeated at least
twice.
Cell migration (time lapse) studies. Time-lapse studies were performed on an
Olympus IX81 researchmicroscope (Olympus America, Center Valley, PA) equipped
with a Proscan motorized stage (Prior Scientific Instruments Ltd., Rockland, MA)
and placed in a temperature and CO2 controlled chamber (LiveCell Incubation
System, Neue Biosciences, Camp Hill, PA). Using relief-contrast optics, images were
taken every 10 minutes for 16 hours 40 minutes (100 images) for cell migration
studies. Metamorph software (Molecular Devices Corporations, Chicago, IL) was
used for the image analysis and the cell velocities were calculated using the cell track
module in each tracked location. More detailed description can be found elsewhere16.
The tracking experiment was performed immediately after treatments.
MTT assay.Cells were incubatedwith 1.7 mMof Thiazolyl Blue TetrazoliumBromide
(Sigma, cat#M2128) for 4 hours at 37uC. After removal of the supernatant and
washingwith PBS, acid isopropanol solution (isopropanol with 0.4% of 10NHCl) was
added. The results were read at 570 nm on an ELISA reader.
Flow Cytometry. Flow cytometry studies were performed on a FACSCalibur DxP8 at
the GWU Flow Cytometry Core Facility (manufactured by BD Biosciences
and,upgraded by Cytek Development). The analyzer is equipped with three lasers
(providing excitation wavelengths of 488, 637 and 407 nm) and eight detectors for
fluorescence.
Cell Cycle.DNAcontentmeasurement identifies G0/G1-, S- andG2/M- phases of the
cell cycle, whereas EdU incorporation specifically quantifies S-phase. DNA content
measurement utilized the Propidium Iodide/RNase Staining Buffer (BDPharmingen,
cat# 550825) with the addition of 0.1% Triton X-100. Cells were trypsinized with
0.25% Trypsin EDTA (Invitrogen, Gibco, cat# 25200), washed with PBS prior to
fixation in 70% ethyl alcohol, stored at 220uC for 24 hours and then stained. EdU
incorporation was performed with the Click-iT EdU Flow Cytometry Assay kit Alexa
Fluor 647 (Invitrogen, cat# 10424) which was modified for usage with 70% ethyl
alcohol fixation. Cells were incubated with 25 mM of EdU at 37uC for 1 hour prior to
fixation and subsequent staining.
Drug treatment. 308 cells were incubated for ,8–9 hours at 37uC with 7 nM of
Nocodazole (7 mM in DMSO stock solution, Sigma, cat# M1404), washed 2–3 times
with PBS, put in fresh media, incubated for,1–2 hours at 37uC, and then processed
for further experiments.
Oxidative stress S-phase damage reporter. Phospho-Histone cH2A.X (Ser139)
Rabbit Alexa Fluor 488 conjugated antibody (diluted 1:50 in 1% BSA) was used as the
S-phase damage reporter (Cell Signaling Technology, cat# 9719). Rabbit (DA1E) IgG
isotype control Alexa Flour 488 conjugate (Cell Signaling Technology, cat# 2975) was
used as the control antibody (also diluted 1:50 in 1% BSA).
Data analysis. The statistical analysis of data was performed by means of InStat 3
software (Graphpad Software, Inc., San Diego, CA). Data was subjected to a
descriptive statistics analysis with Kolmogorov-Smirnov test for Gaussian
distribution. Depending on the sample sizes, parametric or non-parametric analysis
was used to determine themeans and standard error of themean (SEM), and standard
deviation values. The differences between groups were determined by two tail
unpaired t-tests. Data were considered significant for p-values , 0.05 (marked as
single star), and p-values , 0.01 (double star) and , 0.001 (triple star) were
considered as extremely significant. Flow cytometry data were analyzed with FlowJo
7.6.5 analysis software from Tree Star. Statistics from Probability Binning
Comparison (Chi-Squared Test) and Kolmogorov-Smirnov Test ( K-S test, Dm – D
maximum value and Dcr – D critical value) indicating the confidence interval with
which one can make the assertion that two flow cytometric populations are different
was used for data comparison analysis29. TheDcr – value was normalized over control
populations in order to accommodate minor variations due to biological factors.
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